Global Seasonal Influenza Market By Type (Influenza A Viruses, Influenza B Viruses, Influenza C Virus, Influenza D Viruses, Others), Treatment (Antiviral, Neuraminidase Inhibitors, Vaccination, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Seasonal Influenza Market
Seasonal influenza market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of seasonal influenza worldwide and emerging markets are the factors responsible for the growth of this market.
Growing cases of pneumonia disease drives the seasonal influenza market. However, availability of diagnostic test & increased advancement in the treatment of seasonal influenza infection, minimum side effects with the vaccination will also boost up the seasonal influenza market. Furthermore, longer timelines for the production of vaccines and stringent FDA guidelines for the drug approval of new drug may hamper the seasonal influenza market.
Seasonal influenza is the acute respiratory infection caused by the influenza virus. Symptoms of the seasonal influenza flu are sudden onset of fever, dry cough, headache, muscle and joint pain, fatigue, sore throat and runny nose. Pregnant women, children under 59 months/under 5 years, elderly population and people with chronic diseases are at higher risk of seasonal influenza.
This seasonal influenza market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Seasonal Influenza Market Scope and Market Size
Seasonal influenza market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel.
- On the basis of type, the seasonal influenza market is segmented into influenza A viruses, influenza B viruses, influenza C virus, influenza D viruses and others. Influenza A viruses further divided into hemagglutinin and neuraminidase.
- On the basis of treatment, the seasonal influenza market is segmented into antiviral, neuraminidase inhibitors, vaccination and others. Treatment by vaccination is further divided into trivalent and quadrivalent
- Route of administration segment of seasonal influenza market is segmented into oral, parenteral, and others
- On the basis of end-users, the seasonal influenza market is segmented into hospitals, specialty clinics and others
- On the basis of distribution channel, the seasonal influenza market has also been segmented into hospital pharmacy, retail pharmacy, others
Seasonal Influenza Market Country Level Analysis
Seasonal influenza market is analysed and market size information is provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the seasonal influenza market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Saudi Arabia, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to the presence of key manufacture of the product, high R & D and healthcare expenditure with skilled professionals. Europe is considered to be second largest market for seasonal influenza due to increased prevalence of influenza infection. Asia-Pacific is expected to account for the largest market share over coming years for the seasonal influenza market due to increased government awareness programs and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Seasonal influenza market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Seasonal influenza Market Share Analysis
Seasonal influenza market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to seasonal influenza market.
The major players covered in the seasonal influenza market are AstraZeneca, Novartis AG, Pfizer Inc., GlaxoSmithKline Plc., Sanofi, Shionogi Inc., Sinovac Biotech Ltd. and Abbott Laboratories among others.
Customization Available: Global Seasonal Influenza Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.